TCIM
TMO icon

TIAA CREF Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

TIAA CREF Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$276M Buy
1,009,931
+30,861
+3% +$7.68M 0.2% 103
2018
Q4 		$219M Sell
979,070
-16,796
-2% -$3.94M 0.17% 124
2018
Q3 		$243M Sell
995,866
-152,297
-13% -$35M 0.16% 135
2018
Q2 		$238M Sell
1,148,163
-61,777
-5% -$13.1M 0.16% 140
2018
Q1 		$250M Buy
1,209,940
+66,388
+6% +$13.9M 0.17% 124
2017
Q4 		$217M Sell
1,143,552
-207,161
-15% -$39.7M 0.14% 149
2017
Q3 		$256M Buy
1,350,713
+93,213
+7% +$16.9M 0.17% 130
2017
Q2 		$219M Sell
1,257,500
-314,433
-20% -$52.8M 0.15% 147
2017
Q1 		$241M Sell
1,571,933
-168,768
-10% -$25.8M 0.17% 122
2016
Q4 		$246M Sell
1,740,701
-692,238
-28% -$102M 0.18% 111
2016
Q3 		$387K Sell
2,432,939
-133,694
-5% -$20.6M 0.24% 92
2016
Q2 		$379M Buy
2,566,633
+3,318
+0.1% +$490K 0.29% 72
2016
Q1 		$363M Buy
2,563,315
+39,132
+2% +$5.24M 0.28% 80
2015
Q4 		$358M Sell
2,524,183
-362,247
-13% -$48.3M 0.27% 81
2015
Q3 		$353M Sell
2,886,430
-165,564
-5% -$21.6M 0.28% 72
2015
Q2 		$396M Sell
3,051,994
-121,057
-4% -$15.8M 0.28% 69
2015
Q1 		$426M Buy
3,173,051
+216,824
+7% +$28M 0.3% 68
2014
Q4 		$370M Buy
2,956,227
+341,448
+13% +$41.5M 0.26% 83
2014
Q3 		$318M Buy
2,614,779
+286,369
+12% +$34.8M 0.23% 92
2014
Q2 		$275M Sell
2,328,410
-55,413
-2% -$6.52M 0.19% 114
2014
Q1 		$287M Buy
2,383,823
+643,223
+37% +$76.5M 0.21% 104
2013
Q4 		$194M Sell
1,740,600
-67,829
-4% -$6.74M 0.14% 154
2013
Q3 		$167M Sell
1,808,429
-370,504
-17% -$33.5M 0.13% 177
2013
Q2 		$184M Buy
+2,178,933
New +$181M 0.15% 148

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TIAA CREF Investment Management's TMO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2019, buying an estimated $7.68M and bringing the position to 1,009,931 shares worth $276M. The position accounts for 0.2% of the portfolio, ranked #103.

TIAA CREF Investment Management first reported a position in TMO in Q2 2013 and has held it in 24 quarters since. The position peaked at $426M in Q1 2015. 1,522 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

  • TIAA CREF Investment Management held 1,009,931 shares of Thermo Fisher Scientific worth $276M as of Q1 2019.
  • TIAA CREF Investment Management bought 30,861 Thermo Fisher Scientific shares in Q1 2019, an estimated $7.68M.
  • Thermo Fisher Scientific made up 0.2% of TIAA CREF Investment Management's portfolio in Q1 2019, its #103 holding.
  • TIAA CREF Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Thermo Fisher Scientific position peaked at $426M in Q1 2015.
  • 1,522 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.